What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.5% in the afternoon session after the stock ...

4D said it will receive an $85 million upfront cash payment from Otsuka and expects to receive at least $50 million of cost sharing from its partner over the next three years for development ...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is one of the top long-term biotechnology stocks to buy. On October 17, Tonix Pharmaceuticals (NASDAQ:TNXP) presented encouraging preclinical data for ...

New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative medicines for patients worldwideStrategy centers on broadening access to global ...

ETHZilla has pivoted from biotech to become a major Ethereum treasury and infrastructure company, holding 102,326 ETH worth ...

The CSL Ltd (ASX: CSL) share price has been sold off this year. Do analysts think this could be a great time to buy? Let's find ...

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Duopharma Biotech Berhad (KLSE:DPHARMA) as an investment opportunity by projecting its future cash ...

Shares drop as AUB confirms takeover proposal; Flight Centre sells Thai, Indonesian hotels; Liontown burns through cash in Q1 ...

Dyne Therapeutics’ stock sees record rally, but one analyst says it could still climb a lot further, after a rival got bought ...

MapLight has become the second Massachusetts-linked biotech to go public this year. The company sold 14.75 million shares at ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...

Nex-z is one of two late-stage projects on the go at Intellia, a specialist in CRISPR gene-editing co-founded by Nobel Prize ...